Clinical Trial: Sustained Release Oral Formulation for Treatment of Parkinson's Disease
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Idiopathic Parkinson Disease
Study Type: INTERVENTIONAL
Official Title: Sustained Release Oral Formulation for Treatment of Parkinson's Disease
Brief Summary:
Achieving sustained blood levels of carbidopa/levodopa has been a challenge in the treatment of PD and although levodopa remains the most commonly used drug, motor fluctuations remain a major disability especially in advanced Parkinson's disease.The aim of this study is to determine the efficacy of a novel oral carbidopa-levodopa formulation in achieving a sustained blood level of levodopa and carbidopa in PD.
Read more